XML 70 R59.htm IDEA: XBRL DOCUMENT v3.19.1

Subsequent Events (Details Narrative) - Subsequent Event [Member] - USD ($) $ in Thousands	Feb. 18, 2019	Feb. 08, 2019	Jan. 23, 2019
Eyemax [Member] | Sean Brynjelsen [Member]
Ownership interest percentage	33.00%
Licensing and Supply Agreement [Member] | Upon Execution of the Agreement [Member]
Payment of license			$ 350
Licensing and Supply Agreement [Member] | Upon Successful Bioequivalence Study [Member]
Payment of license			350
Licensing and Supply Agreement [Member] | Upon NDA Acceptance [Member]
Payment of license			325
Licensing and Supply Agreement [Member] | Upon NDA Approval [Member]
Payment of license			325
Licensing and Supply Agreement [Member] | Upon Issuance of Patent [Member]
Payment of license			650
Licensing and Supply Agreement [Member] | Product Sales [Member]
Payment of license			500
Licensing and Supply Agreement [Member] | Maximum [Member] | Calendar Year [Member]
Payment of license			$ 10,000
Exclusive Licensing and Supply Agreement - 202 [Member]
Percentage for additional profit for commercial sale of product		50.00%
Exclusive Licensing and Supply Agreement - 202 [Member] | Upon FDA Approval [Member]
Payment of license		$ 750
Exclusive Licensing and Supply Agreement - 203 [Member]
Percentage for additional profit for commercial sale of product		50.00%
Exclusive Licensing and Supply Agreement - 203 [Member] | Upon FDA Approval [Member]
Payment of license		$ 750
Amended and Restated Agreement [Member] | Maximum [Member]
Royalties	$ 2,000
Liqmeds Worldwide Limited ("LMW") [Member]
Percentage for product profit from commercial sales			35.00%
Agreement term			10 years
Liqmeds Worldwide Limited ("LMW") [Member] | Licensing and Supply Agreement [Member] | Maximum [Member]
Payment of license			$ 2,500
Sintetica SA [Member] | Exclusive Licensing and Supply Agreement - 202 [Member]
Payment of license		$ 2,000
Percentage for marketing fees		5.00%
Proceeds from license received		$ 500
Percentage for additional profit for commercial sale of product		50.00%
Agreement term for commercial sale of product		10 years
Sintetica SA [Member] | Exclusive Licensing and Supply Agreement - 203 [Member]
Payment of license		$ 1,000
Percentage for marketing fees		5.00%
Proceeds from license received		$ 500
Percentage for additional profit for commercial sale of product		50.00%
Agreement term for commercial sale of product		10 years
Eyemax [Member] | Amended and Restated Agreement [Member]
Description for milestone payment	Pursuant to the Amended Agreement, the Company remain obligated to pay Eyemax two milestones: (i) one milestone payment for $250,000 upon regulatory approval in the territory by the FDA of the first single agent product and (ii) one milestone payment for $500,000 following the first commercial sale of the first single agent product in the territory.
Eyemax [Member] | Amended and Restated Agreement [Member] | One Milestone [Member]
Payment for milestone	$ 250
Eyemax [Member] | Amended and Restated Agreement [Member] | Two Milestone [Member]
Payment for milestone	500
Bausch Health Ireland Limited [Member] | Asset Purchase Agreement [Member]
Payment for milestone	500
Bausch Health Ireland Limited [Member] | Asset Purchase Agreement [Member] | Commercial Milestone [Member]
Payment for milestone	$ 2,500

X

- Definition

The agreement is for an initial term.

+ References

No definition available.

+ Details

Name:	ETON_AgreementTerm
Namespace Prefix:	ETON_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Agreement term for commercial sale of product.

+ References

No definition available.

+ Details

Name:	ETON_AgreementTermForCommercialSaleOfProduct
Namespace Prefix:	ETON_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Description for milestone payment.

+ References

No definition available.

+ Details

Name:	ETON_DescriptionForMilestonePayment
Namespace Prefix:	ETON_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Payment for milestone.

+ References

No definition available.

+ Details

Name:	ETON_PaymentForMilestone
Namespace Prefix:	ETON_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Percentage for marketing fees.

+ References

No definition available.

+ Details

Name:	ETON_PercentageForMarketingFees
Namespace Prefix:	ETON_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Percentage for product profit from commercial sales.

+ References

No definition available.

+ Details

Name:	ETON_PercentageForProductProfitFromCommercialSales
Namespace Prefix:	ETON_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.15(a))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.15(5))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

+ Details

Name:	us-gaap_AccruedRoyaltiesCurrentAndNoncurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

+ Details

Name:	us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

X

- Definition

The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3213-108585

+ Details

Name:	us-gaap_PaymentsToAcquireIntangibleAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Cash received from licensees for license fees during the current period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3536-108585

+ Details

Name:	us-gaap_ProceedsFromLicenseFeesReceived
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Percentage of subsidiary's or equity investee's stock owned by parent company before stock transaction.

+ References

No definition available.

+ Details

Name:	us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_OwnershipAxis=ETON_EyemaxMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TitleOfIndividualAxis=ETON_SeanBrynjelsenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=ETON_LicensingAndSupplyAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementScenarioAxis=ETON_UponExecutionAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementScenarioAxis=ETON_UponSuccessfulBioequivalenceStudyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementScenarioAxis=ETON_UponNDAAcceptanceMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementScenarioAxis=ETON_UponNDApprovalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementScenarioAxis=ETON_UponIssuanceOfPatentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementScenarioAxis=ETON_ProductSalesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementScenarioAxis=ETON_CalendarYearMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=ETON_ExclusiveLicensingAndSupplyAgreementTwoHundredTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementScenarioAxis=ETON_UponFDAApprovalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=ETON_ExclusiveLicensingAndSupplyAgreementTwoHundredThreeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=ETON_AmendedAndRestatedAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	dei_LegalEntityAxis=ETON_LiqmedsWorldwideLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	dei_LegalEntityAxis=ETON_SinteticaSAMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	dei_LegalEntityAxis=ETON_EyemaxLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementScenarioAxis=ETON_OneMilestoneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementScenarioAxis=ETON_TwoMilestoneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	dei_LegalEntityAxis=ETON_BauschHealthIrelandLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=ETON_AssetPurchaseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementScenarioAxis=ETON_CommercialMilestoneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: